These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 796739

  • 21. Is a "low" dose of prednisone better than a "high" dose at the time of renal transplantation?
    Stabile C, Vincenti F, Garovoy M, Duca R, Melzer J, Feduska NJ, Salvatierra O, Amend WJ.
    Braz J Med Biol Res; 1986; 19(3):355-66. PubMed ID: 3297218
    [Abstract] [Full Text] [Related]

  • 22. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 23. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT, Deierhoi MH, Hudson S, Barber WH, Barger BO, Phillips MG, Diethelm AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract] [Full Text] [Related]

  • 24. Alternate-day steroids in children after renal transplantation.
    Potter DE, Holliday MA, Wilson CJ, Salvatierra O, Belzer FO.
    Transplant Proc; 1975 Mar; 7(1):79-82. PubMed ID: 47201
    [No Abstract] [Full Text] [Related]

  • 25. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC, Rohrer RM, Kaplan MM.
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [Abstract] [Full Text] [Related]

  • 26. A controlled trial of anticoagulants in cadaveric renal transplantation.
    Barnes AD, Coles GA, White HJ.
    Transplantation; 1974 May; 17(5):491-4. PubMed ID: 4597178
    [No Abstract] [Full Text] [Related]

  • 27. Alternate day steroids and blood pressure control after renal transplantation.
    McHugh MI, Tanboga H, Wilkinson R.
    Proc Eur Dial Transplant Assoc; 1980 May; 17():496-501. PubMed ID: 7017696
    [Abstract] [Full Text] [Related]

  • 28. Factors influencing the improvement in cadaveric renal transplant survival in pediatric recipients.
    Ettenger RB, Rosenthal JT, Marik J, Forsythe S, Malekzadeh MH, Kamil E, Salusky IB, Fine RN.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1693-5. PubMed ID: 2652554
    [No Abstract] [Full Text] [Related]

  • 29. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z, Wałaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradsky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Nagy KK, Hickey D.
    Ann Transplant; 2002 Feb; 7(3):28-31. PubMed ID: 12465429
    [Abstract] [Full Text] [Related]

  • 30. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 31. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
    Jakobsen A, Sødal G, Flatmark A, Thorsby E.
    Scand J Urol Nephrol Suppl; 1977 Aug; (42):94-6. PubMed ID: 356233
    [Abstract] [Full Text] [Related]

  • 32. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
    Canadian Multicentre Transplant Study Group.
    N Engl J Med; 1986 May 08; 314(19):1219-25. PubMed ID: 2871486
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Permanent withdrawal of prednisone in nekro-kidney transplantation.
    Thaysen JH, Løkkegaard H.
    Scand J Urol Nephrol Suppl; 1977 May 08; (42):198-9. PubMed ID: 356210
    [Abstract] [Full Text] [Related]

  • 35. Steroid-induced glaucoma and cataract in renal transplant recipients.
    Ticho U, Durst A, Licht A, Berkowitz S.
    Isr J Med Sci; 1977 Sep 08; 13(9):871-4. PubMed ID: 336581
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM, Sánchez J, Sánchez P, García J, Orero E, Beneyto I, Ros F.
    Transplant Proc; 1992 Dec 08; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract] [Full Text] [Related]

  • 38. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
    Knight RJ, Podder H, Kerman RH, Lawless A, Katz SM, Van Buren CT, Gaber AO, Kahan BD.
    Transplantation; 2010 Mar 27; 89(6):727-32. PubMed ID: 20195219
    [Abstract] [Full Text] [Related]

  • 39. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1987 Feb 27; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract] [Full Text] [Related]

  • 40. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group.
    Ann Surg; 2008 Oct 27; 248(4):564-77. PubMed ID: 18936569
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.